White Papers
-
A Guide To Digital Endpoints In Major Depressive Disorder
3/7/2025
The integration of digital health technologies (DHTs) in clinical trials for Major Depressive Disorder (MDD) is transforming how symptom severity and treatment efficacy are measured.
-
The Evolution Of Technology For Safety Notifications
3/6/2025
Discover how a digital-first approach empowers sponsors to optimize safety management and drive operational efficiency in an increasingly complex, global clinical landscape.
-
Hepatitis B - Global Clinical Trial Landscape
3/6/2025
As Hepatitis B virus (HBV) clinical trials advance, refining therapeutic endpoints and integrating novel treatment strategies are essential to transforming Hepatitis B management.
-
Antibody-Drug Conjugates: 'Magic Bullets' Become Reality
2/19/2025
Cancer therapy has evolved from potent chemotherapy to targeted biological therapy, including antibody-drug conjugates (ADCs). Learn more about ADCs’ makeup, mechanisms, and the development landscape.
-
Elevating Patient Centricity In Clinical Trials
2/17/2025
How can the integration of patient perspectives throughout the clinical trial process enhance engagement and outcomes?
-
Improving Access And Outcomes For All Clinical Trial Stakeholders
2/14/2025
Delve into the logistical and financial obstacles faced by stakeholders in clinical trials, highlighting the need for balance in improving the participant experience while managing operational efficiency.
-
5 Essential Capabilities For Decentralized Clinical Trials
2/3/2025
Learn how to develop and utilize a successful DCT framework, enabling your study to enhance patient access, improve data quality, and streamline study operations.
-
Oncolytic Virus Therapy: Global Clinical Trial Landscape (2024)
1/30/2025
Oncolytic virus (OV) While oncolytic virus (OV) therapy holds significant promise, addressing immunological challenges and navigating the evolving regulatory environment are critical for its successful integration into clinical practice.
-
Triple-Negative Breast Cancer: Global Clinical Trial Landscape
1/30/2025
With over 1,500 TNBC-focused clinical trials since 2019, research efforts into Triple-negative breast cancer (TNBC) treatments are accelerating despite challenges such as drug resistance.
-
What Is Healthcare Data Interoperability And Why Does It Matter For Clinical Research?
1/28/2025
Explore how healthcare data interoperability can transform patient outcomes, streamline clinical research, and enhance efficiencies while addressing key challenges and global initiatives.